Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Hormones | 10 | 2019 | 71 | 1.940 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 11 | 2019 | 55 | 1.540 |
Why?
|
| Receptors, Thyroid Hormone | 8 | 2015 | 87 | 1.370 |
Why?
|
| Liver | 12 | 2025 | 1876 | 0.990 |
Why?
|
| Co-Repressor Proteins | 3 | 2015 | 39 | 0.970 |
Why?
|
| Nuclear Proteins | 6 | 2017 | 1351 | 0.670 |
Why?
|
| Thyroid Gland | 4 | 2015 | 117 | 0.650 |
Why?
|
| Thyroid Hormone Receptors beta | 5 | 2017 | 22 | 0.650 |
Why?
|
| Triiodothyronine | 5 | 2014 | 73 | 0.600 |
Why?
|
| Hypothyroidism | 4 | 2017 | 100 | 0.580 |
Why?
|
| Energy Metabolism | 4 | 2025 | 815 | 0.540 |
Why?
|
| Repressor Proteins | 4 | 2009 | 874 | 0.510 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 2669 | 0.490 |
Why?
|
| Cholesterol | 4 | 2019 | 574 | 0.470 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2015 | 72 | 0.460 |
Why?
|
| Sulfotransferases | 3 | 2004 | 28 | 0.450 |
Why?
|
| Fructose | 3 | 2021 | 63 | 0.450 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 3 | 2019 | 7 | 0.360 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 1762 | 0.340 |
Why?
|
| Lipid Metabolism | 3 | 2025 | 389 | 0.320 |
Why?
|
| Animals | 31 | 2025 | 36524 | 0.300 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 3 | 2019 | 38 | 0.290 |
Why?
|
| Hepatocytes | 2 | 2008 | 245 | 0.280 |
Why?
|
| Mice, Knockout | 9 | 2025 | 4011 | 0.260 |
Why?
|
| Thyroxine | 4 | 2019 | 76 | 0.260 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 3 | 2025 | 189 | 0.260 |
Why?
|
| Thyrotropin | 4 | 2019 | 62 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 5 | 2025 | 1434 | 0.250 |
Why?
|
| Protein Binding | 6 | 2015 | 1861 | 0.230 |
Why?
|
| Mice | 19 | 2025 | 19048 | 0.220 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2025 | 323 | 0.210 |
Why?
|
| Transcription Factors | 4 | 2025 | 2735 | 0.200 |
Why?
|
| Circadian Rhythm | 1 | 2025 | 298 | 0.200 |
Why?
|
| Succinic Acid | 1 | 2022 | 15 | 0.200 |
Why?
|
| 5' Untranslated Regions | 1 | 2002 | 61 | 0.190 |
Why?
|
| Orphan Nuclear Receptors | 2 | 2014 | 21 | 0.190 |
Why?
|
| Liver X Receptors | 2 | 2014 | 19 | 0.190 |
Why?
|
| Systems Analysis | 1 | 2021 | 15 | 0.180 |
Why?
|
| Triglycerides | 2 | 2021 | 618 | 0.180 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 71 | 0.180 |
Why?
|
| Introns | 1 | 2002 | 319 | 0.180 |
Why?
|
| Lipogenesis | 2 | 2018 | 59 | 0.180 |
Why?
|
| Metabolomics | 1 | 2025 | 471 | 0.170 |
Why?
|
| Fibroblast Growth Factors | 2 | 2014 | 163 | 0.170 |
Why?
|
| Hypertriglyceridemia | 1 | 2021 | 114 | 0.170 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2020 | 18 | 0.160 |
Why?
|
| Food Deprivation | 1 | 2020 | 34 | 0.160 |
Why?
|
| Glucagon | 1 | 2020 | 184 | 0.160 |
Why?
|
| Glucosides | 1 | 2020 | 48 | 0.160 |
Why?
|
| Exons | 1 | 2002 | 839 | 0.160 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2019 | 14 | 0.160 |
Why?
|
| Benzhydryl Compounds | 1 | 2020 | 68 | 0.150 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2018 | 10 | 0.150 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2018 | 8 | 0.150 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 2018 | 9 | 0.150 |
Why?
|
| Signal Transduction | 6 | 2017 | 4938 | 0.150 |
Why?
|
| Insulin | 2 | 2021 | 1260 | 0.140 |
Why?
|
| Mutation | 5 | 2017 | 6350 | 0.140 |
Why?
|
| Glucose | 1 | 2023 | 926 | 0.140 |
Why?
|
| Fructose Intolerance | 1 | 2017 | 3 | 0.140 |
Why?
|
| Transcriptome | 1 | 2025 | 1134 | 0.140 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2018 | 82 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1922 | 0.140 |
Why?
|
| Rats | 6 | 2025 | 3876 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 7 | 2025 | 4883 | 0.130 |
Why?
|
| Pituitary Gland | 2 | 2014 | 89 | 0.120 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 3978 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2019 | 1138 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 150 | 0.120 |
Why?
|
| Nuclear Receptor Coactivator 1 | 2 | 2014 | 244 | 0.120 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 125 | 0.120 |
Why?
|
| Body Weight | 1 | 2019 | 1042 | 0.120 |
Why?
|
| Gene Expression | 2 | 2011 | 1622 | 0.120 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 80 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2015 | 442 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 823 | 0.110 |
Why?
|
| Lipotropic Agents | 1 | 2014 | 6 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 219 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 610 | 0.110 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2014 | 15 | 0.110 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2014 | 60 | 0.110 |
Why?
|
| Models, Animal | 1 | 2015 | 485 | 0.110 |
Why?
|
| RNA, Messenger | 5 | 2021 | 2915 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 1626 | 0.100 |
Why?
|
| Lipids | 4 | 2023 | 565 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 700 | 0.100 |
Why?
|
| Regeneration | 1 | 2015 | 229 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 787 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 390 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 198 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 456 | 0.100 |
Why?
|
| Ligands | 2 | 2012 | 573 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 514 | 0.100 |
Why?
|
| Retinoid X Receptors | 2 | 2010 | 32 | 0.100 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 815 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2003 | 295 | 0.100 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2014 | 211 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2014 | 300 | 0.100 |
Why?
|
| Chromatin | 1 | 2015 | 617 | 0.090 |
Why?
|
| Cell Line | 4 | 2015 | 2866 | 0.090 |
Why?
|
| Mice, Mutant Strains | 2 | 2011 | 400 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 651 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2017 | 3181 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2011 | 120 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2014 | 396 | 0.080 |
Why?
|
| Male | 16 | 2025 | 66216 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2015 | 1075 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 485 | 0.080 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2007 | 41 | 0.080 |
Why?
|
| PPAR alpha | 1 | 2010 | 55 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2015 | 2043 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2008 | 2178 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 69 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2009 | 300 | 0.070 |
Why?
|
| Base Sequence | 2 | 2003 | 3181 | 0.070 |
Why?
|
| Species Specificity | 1 | 2009 | 570 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 1880 | 0.070 |
Why?
|
| Tosyl Compounds | 1 | 2007 | 24 | 0.070 |
Why?
|
| Anilides | 1 | 2007 | 58 | 0.070 |
Why?
|
| Humans | 14 | 2025 | 134223 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1416 | 0.070 |
Why?
|
| Nitriles | 1 | 2007 | 155 | 0.070 |
Why?
|
| Binding, Competitive | 2 | 2004 | 194 | 0.060 |
Why?
|
| Obesity | 1 | 2018 | 2449 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1621 | 0.060 |
Why?
|
| Acetylation | 2 | 2017 | 196 | 0.060 |
Why?
|
| Receptors, Calcitriol | 1 | 2006 | 74 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 1070 | 0.060 |
Why?
|
| Coenzyme A | 1 | 2025 | 6 | 0.060 |
Why?
|
| Receptors, Androgen | 2 | 2007 | 434 | 0.060 |
Why?
|
| Hormone Antagonists | 1 | 2004 | 62 | 0.060 |
Why?
|
| Circadian Clocks | 1 | 2025 | 72 | 0.060 |
Why?
|
| Mifepristone | 1 | 2004 | 139 | 0.060 |
Why?
|
| 5' Flanking Region | 1 | 2004 | 10 | 0.060 |
Why?
|
| Adipocytes | 1 | 2006 | 179 | 0.060 |
Why?
|
| Nuclear Matrix | 1 | 2004 | 21 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2793 | 0.060 |
Why?
|
| Binding Sites | 2 | 2004 | 1386 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 54 | 0.050 |
Why?
|
| Succinates | 1 | 2022 | 20 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2003 | 94 | 0.050 |
Why?
|
| Transcription Initiation Site | 1 | 2002 | 34 | 0.050 |
Why?
|
| Sex Factors | 2 | 2004 | 1388 | 0.050 |
Why?
|
| Citric Acid Cycle | 1 | 2022 | 50 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 3057 | 0.050 |
Why?
|
| Mice, Inbred C3H | 1 | 2021 | 123 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2025 | 830 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 1308 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 912 | 0.040 |
Why?
|
| Female | 9 | 2025 | 72055 | 0.040 |
Why?
|
| Gene Duplication | 1 | 2002 | 372 | 0.040 |
Why?
|
| Haplotypes | 1 | 2021 | 559 | 0.040 |
Why?
|
| Lipolysis | 1 | 2020 | 83 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2002 | 379 | 0.040 |
Why?
|
| Calcification, Physiologic | 1 | 2019 | 24 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 400 | 0.040 |
Why?
|
| Bone Development | 1 | 2019 | 60 | 0.040 |
Why?
|
| Epinephrine | 1 | 2020 | 182 | 0.040 |
Why?
|
| Receptors, Somatotropin | 1 | 1998 | 9 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 227 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2015 | 691 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2018 | 41 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 751 | 0.040 |
Why?
|
| Intestines | 1 | 2022 | 614 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 63 | 0.040 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 1626 | 0.040 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 22 | 0.040 |
Why?
|
| Protein Phosphatase 2C | 1 | 2018 | 60 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 2538 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 318 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 547 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 398 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2021 | 948 | 0.030 |
Why?
|
| Weight Gain | 1 | 2019 | 413 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 1998 | 337 | 0.030 |
Why?
|
| Bone Density | 1 | 2019 | 377 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 2948 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 1835 | 0.030 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2015 | 6 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2015 | 31 | 0.030 |
Why?
|
| Xenopus | 1 | 2015 | 115 | 0.030 |
Why?
|
| NAD | 1 | 2015 | 51 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 98 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 1087 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 825 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 99 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 718 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2020 | 1196 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2015 | 55 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 745 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 250 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 390 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 4800 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 651 | 0.030 |
Why?
|
| Hyperthyroidism | 1 | 2014 | 26 | 0.030 |
Why?
|
| Weight Loss | 1 | 2017 | 518 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 572 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1132 | 0.030 |
Why?
|
| Adipose Tissue, Brown | 1 | 2014 | 87 | 0.030 |
Why?
|
| Transfection | 2 | 2006 | 1099 | 0.030 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 2012 | 10 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 914 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 199 | 0.020 |
Why?
|
| Genes, erbA | 1 | 2011 | 1 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5225 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4611 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 1715 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2014 | 215 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 811 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 1436 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2011 | 541 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2010 | 93 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 97 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 1043 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1333 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 396 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 7244 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2007 | 319 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2006 | 58 | 0.020 |
Why?
|
| Calcitriol | 1 | 2006 | 80 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 1109 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2006 | 263 | 0.010 |
Why?
|
| Androgens | 1 | 2007 | 300 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 2004 | 74 | 0.010 |
Why?
|
| RNA Interference | 1 | 2006 | 549 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 721 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 1404 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 1538 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 20648 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 21822 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 29431 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1854 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 31963 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 3800 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 6595 | 0.010 |
Why?
|